| Product Description |
 |
Mechanism of Action
Relora is an exciting new natural anti-abnormal apprehension fearfulness stress relief ingredient to control stress related eating and drinking that has the added value of being non-sedating with potential anti-depressant properties. In central nervous system receptor binding essays, the plant extracts in Relora bind to several important targets associated with abnormal apprehension fearfulness. It does not bind to the benzodiazepine receptors that would cause sedation, yet has the relaxing qualities of the benzodiazepine class of drugs in a validated anxiolytic animal model. In addition, it normalizes hormone levels associated with stress-induced obesity and eating/drinking behavior.
Stress is being shown to lay a significant role in a wide variety of conditions and problem states. Recent work from the National Institute of Health (NIH) and other major research centers has demonstrated that stress is a significant contributor to immune dysfunction, cardiovascular problem, other age-related Malfunction of mind or bodys, and to excessive body fat. Over 20% of adults have an obesity-like condition characterized by excessive abdominal fat. This condition is related to stress-induced hormone imbalances, especially imbalances of cortisol and DHEA. Until now, the only course of action for losing this fat has been stress reduction with exercise and diet. Relora can normalize cortisol and DHEA levels in stressed individuals, induce relaxation, and act as an aid in controlling weight and stress related eating and drinking.
|
| |
| Suggested Use
|
|
| The recommended dosage was 200mg. of Relora three times daily (the new and improved Relora dosage is 250mg. three times daily).
|
| |
| Additional Information |
|
| Human TrialsThe first formulation of Relora was tested and found to be a safe, effective, rapid acting, non-sedating dietary supplement that Enhances control mild Uneasyness. Fifty subjects were treated with Relora for two weeks.
|
| |
|
